Shares of Corbus Pharmaceuticals Holdings Inc. /zigman2/quotes/201549545/lastsale CRBP -17.67% advanced 6.82% to $0.47 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP +1.74% rising 0.75% to 14,346.00 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +1.26% rising 0.78% to 35,405.24. This was the stock's third consecutive day of gains. Corbus Pharmaceuticals Holdings Inc. closed $3.53 below its 52-week high ($4.00), which the company reached on February 11th.
The stock outperformed some of its competitors Tuesday, as Fate Therapeutics Inc. /zigman2/quotes/209623007/composite FATE +7.55% fell 0.96% to $41.11, Vanda Pharmaceuticals Inc. /zigman2/quotes/200957783/composite VNDA +1.19% rose 0.33% to $15.21, and Viking Therapeutics Inc. /zigman2/quotes/204618964/composite VKTX -3.92% rose 3.23% to $3.83. Trading volume (1.2 M) eclipsed its 50-day average volume of 1.0 M.